• Sherica Celine
    Sherica Celine
    • over 2 years ago
    • Practical Guidance Journal
    • pa

    Medication Abortion, Telemedicine, and Dobbs—Key Considerations for Healthcare Providers

    By: Claire Marblestone , FOLEY & LARDNER LLP The U.S. Supreme Court’s recent decision in Dobbs v. Jackson Women’s Health Organization 1 has impacted access to abortion in the United States. In light of the Court’s decision, which...
  • Sherica Celine
    Sherica Celine
    • over 3 years ago
    • Practical Guidance Journal
    • pa

    Guidance for Employers on Vaccination and Testing Rules

    By: Richard D. Glovsky, LOCKE LORD LLP This article addresses the COVID-19 vaccine and testing rules promulgated by the Biden Administration. It is an excerpt from the practice note Pandemic Flu/Influenza/Coronavirus (COVID-19): Key Employment Law Issues...
  • Sherica Celine
    Sherica Celine
    • over 1 year ago
    • Practical Guidance Journal
    • pa

    Market Intelligence: Labor & Employment Insights Revealed in the Practical Guidance Private Market Data Survey

    By: Practical Guidance Labor & Employment Attorney Team PRACTICAL GUIDANCE RECENTLY COMPLETED THE ANNUAL PRIVATE MARKET DATA LABOR & EMPLOYMENT SURVEY, which ran from August 25 through September 30, 2023. This survey asked labor and employment...
  • Vinayak Kohli
    Vinayak Kohli
    • over 8 years ago
    • Practical Guidance Journal
    • pa

    Credit Card Data Breaches: Protecting Companies from Hidden Surprises

    By: David A. Zetoony, Bryan Cave LLP and Courtney K. Stout, Davis Wright Tremaine LLP. MOST RETAILERS DO NOT REALIZE THAT BY ACCEPTING credit cards they expose themselves to the risk of a data security breach and significant costs and legal liabilities...
  • Vinayak Kohli
    Vinayak Kohli
    • over 4 years ago
    • Practical Guidance Journal
    • pa

    Avoiding False Claims Act Risks Relating to Federal Funding for Coronavirus (COVID-19) Relief

    By: Matthew D. Jenkins , Hunton Andrews Kurth LLP This article provides an overview of compliance obligations and federal False Claims Act (FCA) risks to healthcare and life sciences companies arising out of three funding streams made available in response...
<>